TITLE

Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice

AUTHOR(S)
Yoshiji, H.; Kuriyama, S.; Noguchi, R.; Yoshii, J.; Ikenaka, Y.; Yanase, K.; Namisaki, T.; Ktade, M.; Uemura, M.; Masaki, T.; Fukui, H.
PUB. DATE
December 2005
SOURCE
Gut;Dec2005, Vol. 54 Issue 12, p1768
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Orchestration of two major classes of angiogenic factors-namely, vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2)-has been shown to play a pivotal role in tumour angiogenesis, including hepatocellular carcinoma (HCC). However, few studies have focused on the direct interaction of these factors on in vivo tumour development and angiogenesis. Aim: To examine the interaction between both factors in murine HCC. Methods: We examined the combination effect of VEGF and Ang-2 overexpression by means of a combination of a retroviral tetracycline (tet) regulated gene manipulating system in vivo, by providing tet in the drinking water, and a conventional plasmid gene expression system. Results: Neither Ang-2 nor VEGF overexpression induced proliferation of HCC cells in vitro. In vivo, although overexpression of Ang-2 did not increase tumour development, simultaneous expression of Ang- 2 and VEGF synergistically augmented tumour growth and angiogenesis in murine HCC. Ang-2 plus VEGF induced tumour development was markedly attenuated by treatment with neutralising monoclonal antibodies against VEGF receptors. Ang-2 plus VEGF overexpression significantly increased the activities of matrix metalloproteinase (MMP)-2 and MMP-9 in the tumour. Suppression of intratumoral VEGF almost completely abolished this augmentation of MMPs. Conclusions: These results suggest that Ang-2 synergistically augments VEGF mediated HCC development and angiogenesis. This proangiogenic activity was exerted only in the presence of VEGF, at least partly mediated via induction of MMP-2 and MMP-9 in the tumour.
ACCESSION #
19160200

 

Related Articles

  • Antivascular Endothelial Growth Factor Monoclonal Antibody Therapy: A Promising Paradigm in Colorectal Cancer. Franson, Paula J.; Lapka, Denise V. // Clinical Journal of Oncology Nursing;Feb2005, Vol. 9 Issue 1, p55 

    Angiogenesis plays an important role in tumor growth and development. Vascular endothelial growth factor (VEGF) is one of the most potent proangiogenic factors and therefore is an ideal target in colorectal cancer therapy. Bevacizumab (Avastinâ„¢, Genentech, Inc., South San Francisco,CA) is...

  • Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. Jianfei Huang; Xialing Zhang; Qi Tang; Feng Zhang; Yuhua Li; Zhenqing Feng; Jin Zhu // Journal of Clinical Pathology;Apr2011, Vol. 64 Issue 4, p343 

    Background Vascular endothelial growth factor receptor 2 (VEGFR2) has been suggested to play an important role in solid tumours. Although several reports have shown the relationship between VEGFR2 expression and hepatocellular carcinoma (HCC), the expression pattern of VEGFR2 in HCC parenchyma...

  • Vascular Endothelial Growth Factor Receptor 2 Antibody, BC001, Attenuates Laser-Induced Choroidal Neovascularization in Rhesus Monkeys (Macaca mulatta). Zhao, Tao; Zhang, Jie; Zhang, Yanyan; Huang, Jingjing; Wang, Xin; Zhang, Yingqian; Zhang, Ming; Yuan, Ye; Xiao, Kai; Li, Hongxia; Zhong, Zhihui // Journal of Ocular Pharmacology & Therapeutics;Dec2015, Vol. 31 Issue 10, p611 

    Purpose: A study was conducted to evaluate the inhibitory effects of vascular endothelial growth factor receptor 2 (VEGFR2) monoclonal antibody, BC001, against laser-induced choroidal neovascularization (CNV).Methods: We induced the experimental CNV in rhesus monkey...

  • Vascular Endothelial Growth Factor and Its Type 2 Receptor in Hepatocellular Carcinoma. Gershtein, E.; Dubova, E.; Shchegolev, A.; Kushkinskii, N. // Bulletin of Experimental Biology & Medicine;Jun2010, Vol. 149 Issue 6, p749 

    Histological analysis demonstrated an increase in the number of blood vessels and expression of CD34 and vascular endothelial growth factor in hepatocellular carcinoma tissue compared to adjacent liver tissue. Increased immunohistochemical expression of vascular endothelial growth factor and the...

  • MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma. Chai, Zong-Tao; Kong, Jian; Zhu, Xiao-Dong; Zhang, Yuan-Yuan; Lu, Lu; Zhou, Jia-Min; Wang, Long-Rong; Zhang, Ke-Zhi; Zhang, Qiang-Bo; Ao, Jian-Yang; Wang, Miao; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background & Aims:microRNAs (miRNAs) have been reported to regulate angiogenesis by down-regulating the expression of pro-angiogenic or anti-angiogenic factors. The aims of this study were to investigate whether miR-26a inhibited angiogenesis by down-regulating vascular endothelial growth factor...

  • Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. Sharma, Bal; Srinivasan, Radhika; Kapil, Shweta; Singla, Bhupesh; Chawla, Yogesh; Chakraborti, Anuradha; Saini, Nitin; Duseja, Ajay; Das, Ashim; Kalra, Naveen; Dhiman, Radha // Molecular Biology Reports;Oct2013, Vol. 40 Issue 10, p5843 

    Tumor angiogenesis, a major requirement for tumor growth and metastasis, is regulated by pro- and anti-angiogenic factors. The aim of this study was to quantify the expression of angiogenic (VEGF, HIF-1α, Angiopiotein-2) and anti-angiogenic (endostatin, angiostatin and Thrombospondin-1)...

  • Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. Monnier, Justin; Piquet-Pellorce, Claire; Feige, Jean-Jacques; Musso, Orlando; Clément, Bruno; Turlin, Bruno; Théret, Nathalie; Samson, Michel; Rosenbaum, Jean // World Journal of Gastroenterology;2/28/2008, Vol. 14 Issue 8, p1182 

    AIM: To study the implication of prokineticin 1 (PK1/EGVEGF) and prokineticin 2 (PK2/Bv8) in hepatocellular carcinoma angiogenesis. METHODS: The gene induction of PK1/EG-VEGF and PK2/Bv8 was investigated in 10 normal, 28 fibrotic and 28 tumoral livers by using real time PCR. Their expression was...

  • Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model. Lang, Sven Arke; Brecht, Isabel; Moser, Christian; Obed, Aiman; Batt, David; Schlitt, Hans Juergen; Geissler, Edward Kenneth; Stoeltzing, Oliver // Langenbeck's Archives of Surgery;May2008, Vol. 393 Issue 3, p333 

    Activation of the mitogen-activated protein kinase–extracellular-signal-regulated kinase (ERK) pathways plays an important role in the progression of hepatocellular carcinoma (HCC). Importantly, Raf kinases are principal effectors within this oncogenic signaling cascade. We hypothesized...

  • VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities. Andreozzi, Mariacarla; Quagliata, Luca; Gsponer, Joel; Ruiz, Christian; Vuaroqueaux, Vincent; Eppenberger-Castori, Serenella; Tornillo, Luigi; Terracciano, Luigi // Angiogenesis;Jul2014, Vol. 17 Issue 3, p519 

    Background: Angiogenesis plays a pivotal role in neoplastic growth and metastasis formation. Vascular endothelial growth factor A (VEGFA) is a major player in physiological and tumour-induced angiogenesis and numerous human tumours have been show to overexpress VEGFA. Moreover increased VEGFA...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics